Expression of EMSY gene in sporadic ovarian cancer

Molecular Biology Reports

Volumn 38, Issue 1, 2011, Pages 359-363

  Altinisik, Julide ^a   Karateke, Ates ^b   Coksuer, Hakan ^b   Ulutin, Turgut ^a   Buyru, Nur ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Zeynep Kamil Maternity and Child Research and Training Hospital   (Turkey)

Author keywords

EMSY; Gene expression; Ovarian cancer; Overexpression

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; EMSY GENE; FEMALE; GENE AMPLIFICATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; ONCOGENE; OVARY CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; REPRESSOR PROTEINS;

EID: 78651065660     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0116-0     Document Type: Article

References (25)

1. RT Greenlee MB Hill-Harmon T Murray M Thun 2001 Cancer statistics CA Cancer J Clin 51 15 36 1:STN:280:DC%2BD3MrjtFGisg%3D%3D 10.3322/canjclin.51.1.15 11577478
2. WP McGuire WJ Hoskins MF Brady PR Kucera EE Partridge KY Look DL Clarke-Pearson M Davidson 1996 Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1 6 1:CAS:528:DyaK28XhtFKiur4%3D 10.1056/NEJM199601043340101 7494563 (Pubitemid 26012496)
3. BA Goff LS Mandel CH Melancon HG Muntz 2004 Frequency of symptoms of ovarian cancer in women presenting to primary care clinics JAMA 291 2705 2712 1:CAS:528:DC%2BD2cXkvVeqs7k%3D 10.1001/jama.291.22.2705 15187051 (Pubitemid 38725419)
4. SA Cannistra 1993 Cancer of the ovary N Engl J Med 329 1550 1559 1:STN:280:DyaK2c%2FhvFKntQ%3D%3D 10.1056/NEJM199311183292108 8155119 (Pubitemid 23332443)
5. CD Runnowicz AL Fields 1999 Screening for gynecologic malignancies: a continuing responsibility Surg Oncol Clin N Am 8 703 724
6. RC Bast Jr 2003 Status of tumor markers in ovarian cancer screening J Clin Oncol 21 200 205 10.1200/JCO.2003.01.068
7. D Sidransky 2002 Emerging molecular markers of cancer Nat Rev Cancer 2 210 219 1:CAS:528:DC%2BD38Xis1KktLs%3D 10.1038/nrc755 11990857
8. AS Dehaghani K Shahriary MA Kashef S Naeimi MJ Fattahi Z Mojtahedi A Ghaderi 2009 Interleukin-18 gene promoter and serum level in women with ovarian cancer Mol Biol Rep 36 2393 2397 10.1007/s11033-009-9469-7
9. F Xu G Wang K Cai R Zhai S Tang 2010 Effects of ovariectomy on microsatellite instability in rat colon tumors induced by 1,2-dimethylhydrazine Mol Biol Rep 37 1397 1401 1:CAS:528:DC%2BC3cXhtlajurc%3D 10.1007/s11033-009- 9523-5 19363658
10. Liao R-Y, Mao C, Qiu L-X, Ding H, Chen Q, Pan H-F (2009) TGFBR1*6A/9A polymorphism and cancer risk: a meta analysis of 13,662 cases and 14,147 controls. Mol Biol Rep. doi: 10.1007/s11033-009-9906-7
11. J Boyd 1998 Molecular genetics of hereditary ovarian cancer Oncology (Huntingt) 12 399 406 1:STN:280:DyaK1c7psFKkuw%3D%3D
12. US Khoo H Ozcelik AN Cheung LW Chow HY Ngan SJ Done AC Liang VW Chan GK Au WF Ng CS Poon YF Leung F Loong P Ip GS Chan IL Andrulis J Lu FC Ho 1999 Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer Oncogene 18 4643 4646 1:CAS:528:DyaK1MXlslCrurc%3D 10.1038/sj.onc.1202847 10467410 (Pubitemid 29405897)
13. L Hosking J Trowsdale H Nicolai E Solomon W Foulkes G Stamp E Signer A Jeffreys 1995 A somatic BRCA1 mutation in an ovarian tumor Nat Genet 9 343 344 1:CAS:528:DyaK2MXkvV2jtbY%3D 10.1038/ng0495-343 7795636
14. A Dobrovick D Simpfendorfer 1997 Methylation of the BRCA1 gene in sporadic breast cancer Cancer Res 57 3347 3350
15. CA Wilson L Ramos MR Villasenar KH Anders MF Press K Clarke B Karlan JJ Chen R Scully D Livingston RH Zuch MH Kanter S Cohen FJ Calzone DJ Slamon 1999 Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas Nat Genet 21 236 240 1:CAS:528:DyaK1MXpsVCrsQ%3D%3D 10.1038/6029 9988281 (Pubitemid 29070375)
16. L Hughes-Davies D Huntsman M Ruas F Fuks J Bye SF Chin J Milner LA Brown F Hsu B Gilks T Nielsen M Schulzer S Chia J Ragaz A Cahn L Linger H Ozdag E Cattaneo ES Jordanova E Schuuring DS Yu A Venkitaraman B Ponder A Doherty S Aparicio D Bentley C Theillet CP Ponting C Caldas T Kouzarides 2003 EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer Cell 115 523 535 1:CAS:528:DC%2BD3sXps1Oht7c%3D 10.1016/S0092-8674(03)00930-9 14651845 (Pubitemid 37506042)
17. JL Hilton JP Geisler JA Rathe H Zogg B DeYoung RE Buller 2002 Inactivation of BRCA1 and BRCA2 in ovarian cancer J Natl Cancer Inst 94 1396 1406 1:CAS:528:DC%2BD38Xnt1Gnurc%3D 12237285
18. CM Ekblad GB Chavali BP Basu SM Freund D Veprintsev L Hughes-Davies T Kouzarides AJ Doherty LS Itzhaki 2005 Binding of EMSY to HP1β: implications for recruitment of HP1β and BS69 EMBO Rep 6 675 680 1:CAS:528: DC%2BD2MXlslWgtrg%3D 10.1038/sj.embor.7400415 15947784 (Pubitemid 41122437)
19. EB Claus JM Schildkraut WD Thompson NJ Risch 1996 The genetic attributable risk of breast and ovarian cancer Cancer 77 2318 2324 1:STN:280:DyaK283isV2jsg%3D%3D 10.1002/(SICI)1097-0142(19960601)77:11<2318:: AID-CNCR21>3.0.CO;2-Z 8635102 (Pubitemid 26162426)
20. J Karlseder R Zeillinger C Schneeberger K Czerwenka P Speiser E Kubista D Birnbaum P Gaudray C Theillet 1994 Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer Genes Chromosom Cancer 9 42 48 1:CAS:528:DyaK2cXmtVWqtbg%3D 10.1002/gcc.2870090108 7507699 (Pubitemid 24007495)
21. S Bekri J Adélaïde S Merscher J Grosgeorge F Caroli-Bosc D Perucca-Lostanlen PM Kelley MJ Pébusque C Theillet D Birnbaum P Gaudray 1997 Detailed map of a region commonly amplified at 11q13 → q14 in human breast carcinoma Cytogenet Cell Genet 79 125 131 1:CAS:528:DyaK1cXislKgtrk%3D 10.1159/000134699 9533029
22. P Schraml G Schwerdtfeger F Burkhalter A Raggi D Schmidt T Ruffalo W King K Wilber MJ Mihatsch H Moch 2003 Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma Am J Pathol 163 985 992 1:CAS:528:DC%2BD3sXnsVCju7g%3D 12937139
23. M Nordling P Karlsson J Wahlström Y Engwall A Wallgren T Martinsson 1998 A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family Cancer Res 58 1372 1375 1:CAS:528:DyaK1cXit1elu7Y%3D 9537232
24. C Rodriguez L Hughes-Davies H Vallès B Orsetti M Cuny L Ursule T Kouzarides C Theillet 2004 Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome Clin Cancer Res 10 5785 5791 1:CAS:528:DC%2BD2cXntlyjs7s%3D 10.1158/1078-0432.CCR-03-0410 15355907 (Pubitemid 39180956)
25. LA Brown J Irving R Parker H Kim JZ Press TA Longacre S Chia A Magliocco N Makretsov B Gilks J Pollack D Huntsman 2006 Amplification of EMSY, a novel oncogene on 11q13 in high grade ovarian surface epithelial carcinomas Gynecol Oncol 100 264 270 1:CAS:528:DC%2BD28XjsFKrsQ%3D%3D 10.1016/j.ygyno.2005.08.026 16236351 (Pubitemid 43075259)